Diodes gets BofA buy rating as earnings growth seen outpacing analog peers

Bank of America initiated coverage of Diodes with a Buy rating and a $135 price target, forecasting 58% annual EPS growth from 2026 to 2028 versus 35% for analog-chip peers. The target is based on 17 times 2028 pro forma EPS, reflecting normalized earnings.

Analysis

The key underwriting risk is that the projected acceleration is measured from normalized 2026 earnings: a cyclical recovery in utilization or customer inventories could produce rapid EPS growth without establishing a durable share-gain trend. Conversely, if the forecast requires sustained share gains, Diodes must demonstrate them against larger analog and power-semiconductor competitors such as Texas Instruments, Analog Devices, and onsemi; aggressive pricing to win sockets could dilute the earnings benefit. The 17x multiple on 2028 pro forma EPS also makes the thesis sensitive to both the distant earnings denominator and the terminal multiple. Without the current share price, detailed 2026–28 estimates, or evidence behind the normalization, the $135 target does not establish attractive upside or a margin of safety. In the next 1–3 months, look for order, inventory, and gross-margin evidence that validates the earnings slope. Over 6–18 months, the more important test is whether growth persists across end markets rather than fading with a semiconductor-cycle rebound. A broad-based recovery could lift peers too, weakening the case that DIOD deserves a premium growth multiple.

Key Decisions for Investors

• Do not trade the price target in isolation. Before initiating a position, verify the current price, the 2026–28 EPS bridge, what 'normalized' earnings exclude, and the end-market assumptions behind the forecast.
• Keep DIOD on a confirmation watchlist for the next earnings reports: improving orders alongside stable or rising gross margin would support the growth thesis; weaker bookings, inventory rebuilding, or margin deterioration would argue against it.
• If taking exposure ahead of confirmation, size it as a cyclical growth position rather than a proven structural compounder. Reassess if management guidance or reported results no longer support the projected earnings trajectory; avoid assigning a numeric stop without current price and volatility data.
• For a relative-value expression, consider DIOD versus a diversified semiconductor exposure only after comparing valuation and estimate revisions. The thesis is falsified if DIOD's earnings revisions lag peers or if its relative performance fails to improve despite sector recovery.